Leverages AI to sift through medical records and precisely match patients to clinical trials, speeding up recruitment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BEKHealth is a clinical‑research tech company that uses AI to scan structured and unstructured electronic medical records (EMRs), identify patients who match trial criteria, and streamline study enrollment processes. Their platform builds detailed, queryable patient cohorts, helps with trial feasibility, and automates pre‑screening to reduce manual chart review.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BEKHealth Management Team
Investors
Boston Millennia Partners
Connecticut Innovations Inc
Excelerate Health Ventures
Hatteras Venture Partners
Martin Ventures
BEKHealth Valuations & Financials
View real-time NPM data on BEKHealth stock including daily BEKHealth stock price estimates, valuation history, and historical share price information. Access BEKHealth financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BEKHealth pricing across six independent market signals. Looking for private company due diligence data sources on BEKHealth? Get in touch to learn more.
Similar Companies
like BEKHealth
Synapticure
Healthcare & Life Sciences
Delivers care which supports patients with neurodegenerative illnesses through virtual access to treatment, monitoring, and coordination.
Epic Sciences
Healthcare & Life Sciences
Provides diagnostic insights into cancer by analyzing circulating tumor cells and related biomarkers for precision therapy.
Cresilon
Healthcare & Life Sciences
Develops plant-based hemostatic gels for rapid bleeding control in veterinary and human care.
TRIO Pharmaceuticals
Healthcare & Life Sciences
Develops bispecific antibodies that target cancer cells and immunosuppressor cells simultaneously, creating dual-action tumor treatments.
Gilgamesh Pharma
Healthcare & Life Sciences
Develops rapid-acting experimental therapies targeting psychiatric and neurological disorders with novel chemical entities.
Noctrix Health
Healthcare & Life Sciences
Delivering a wearable neuromodulation therapy that eases restless limb symptoms and boosts sleep with a clinically proven, drug-free approach.
Procision
Healthcare & Life Sciences
Provides integrated software that automates scheduling, charting, and billing for surgical centers.
ViuHealth
Healthcare & Life Sciences
Enables remote autoimmune management by tracking symptoms, offering lifestyle support, and facilitating continuous coach-led guidance.
Circular Genomics
Healthcare & Life Sciences
Decodes circular RNAs into biomarkers which guide diagnosis and therapy in brain disorders.
FAQ
We have answers
BEKHealth stock does not trade on public stock exchanges. BEKHealth stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BEKHealth stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BEKHealth Stock does not trade on public stock exchanges. In order to sell BEKHealth shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BEKHealth does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BEKHealth share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BEKHealth stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BEKHealth stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BEKHealth stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BEKHealth is a private company and has not had an IPO. There is currently no BEKHealth IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BEKHealth IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
